UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.76B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$447M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$336M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$294M |
| 5 |
GSK
GSK
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$937M |
| 2 |
UBS Group
UBS
|
+$511M |
| 3 |
Microsoft
MSFT
|
+$402M |
| 4 |
Baidu
BIDU
|
+$338M |
| 5 |
Apple
AAPL
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.08% |
| 2 | Consumer Discretionary | 6.75% |
| 3 | Financials | 6.3% |
| 4 | Healthcare | 5.83% |
| 5 | Industrials | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Alto Ingredients
ALTO
$340M
| $2.4M | ﹤0.01% |
441,883
+434,827
| +6,163% | +$2.88M |
|
3377
State Street SPDR FactSet Innovative Technology ETF
XITK
$78.1M
| $2.4M | ﹤0.01% |
11,477
-2,596
| -18% | -$592K |
|
3378
Heron Therapeutics
HRTX
$92.9M
| $2.4M | ﹤0.01% |
147,904
+16,454
| +13% | +$293K |
|
|
MAXR
3379
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.4M | ﹤0.01% |
63,370
+42,703
| +207% | +$1.9M |
|
|
HQL
3380
abrdn Life Sciences Investors
HQL
$627M
| $2.4M | ﹤0.01% |
121,568
+16,784
| +16% | +$346K |
|
3381
Uranium Energy
UEC
$5.57B
| $2.4M | ﹤0.01% |
837,645
-58,011
| -6% | -$127K |
|
|
TELL
3382
DELISTED
Tellurian Inc.
TELL
| $2.4M | ﹤0.01% |
1,023,327
+967,613
| +1,737% | +$2.64M |
|
|
KTF
3383
DWS Municipal Income Trust
KTF
$352M
| $2.39M | ﹤0.01% |
205,386
+6,410
| +3% | +$74K |
|
3384
Sonic Automotive
SAH
$2.61B
| $2.39M | ﹤0.01% |
48,283
+23,952
| +98% | +$1.11M |
|
3385
World Kinect Corp
WKC
$1.86B
| $2.39M | ﹤0.01% |
67,933
+7,006
| +11% | +$238K |
|
3386
CALL
Nutanix
NTNX
$16.9B
| $2.39M | ﹤0.01% |
+90,000
| New | +$2.74M |
|
3387
Cable One
CABO
$212M
| $2.38M | ﹤0.01% |
1,304
-77
| -6% | -$150K |
|
|
SAGE
3388
DELISTED
Sage Therapeutics
SAGE
| $2.38M | ﹤0.01% |
31,855
+20,378
| +178% | +$1.67M |
|
|
TWOU
3389
DELISTED
2U Inc
TWOU
| $2.38M | ﹤0.01% |
2,078
+115
| +6% | +$146K |
|
|
FISV
3390
CALL
Fiserv Inc
FISV
$27.9B
| $2.38M | ﹤0.01% |
20,000
-20,000
| -50% | -$2.3M |
|
3391
ICU Medical
ICUI
$4.61B
| $2.38M | ﹤0.01% |
11,590
-1,671
| -13% | -$353K |
|
|
HEES
3392
DELISTED
H&E Equipment Services
HEES
| $2.38M | ﹤0.01% |
62,550
+8,187
| +15% | +$262K |
|
3393
La-Z-Boy
LZB
$1.69B
| $2.37M | ﹤0.01% |
55,724
+35,857
| +180% | +$1.5M |
|
3394
VanEck Short Muni ETF
SMB
$312M
| $2.37M | ﹤0.01% |
131,233
+52,152
| +66% | +$943K |
|
3395
Tilray
TLRY
$622M
| $2.37M | ﹤0.01% |
10,411
-4,474
| -30% | -$1.05M |
|
3396
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$742M
| $2.36M | ﹤0.01% |
37,904
+3,390
| +10% | +$196K |
|
3397
Affirm
AFRM
$25.2B
| $2.36M | ﹤0.01% |
+33,335
| New | +$3.24M |
|
3398
Emcor
EME
$36B
| $2.35M | ﹤0.01% |
20,983
-3,128
| -13% | -$314K |
|
3399
CALL
Airbnb
ABNB
$107B
| $2.35M | ﹤0.01% |
+12,500
| New | +$2.32M |
|
3400
Concentrix
CNXC
$1.57B
| $2.35M | ﹤0.01% |
15,679
-6,865
| -30% | -$832K |
|
Similar funds
UBS Group's Q1 2021 Portfolio in Review
As of Q1 2021, UBS Group held 9,997 positions worth $301B, up 1.9% from $296B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q1 2021 filing shows 1,505 new, 3,920 increased, 3,391 reduced and 881 closed positions. Its largest new stake was Ferguson: 1,602,252 shares worth $192M. The largest sale was Stellantis, an estimated $937M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS Group's largest Q1 2021 buy was Ferguson: 1,602,252 shares worth $192M.
- UBS Group added most to Alibaba in Q1 2021, an estimated $2.76B increase.
- UBS Group's biggest Q1 2021 reduction was Stellantis, cutting an estimated $937M.
- UBS Group fully exited Tiffany & Co. in Q1 2021, selling an estimated $77.2M.
- UBS Group's ten largest holdings make up 14% of its $301B portfolio in Q1 2021.
- UBS Group opened 1,505 new positions and closed 881 in Q1 2021.
- UBS Group's portfolio value rose 1.9% quarter-over-quarter to $301B.
Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.